As of 2026-09-24, the EV/EBITDA ratio of Syneos Health Inc (SYNH) is
12.15.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SYNH's latest enterprise value
is 7,081.09 mil USD. SYNH's TTM EBITDA according to its financial statements is
582.72 mil USD. Dividing these 2
quantities gives us the above SYNH EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
15.1x - 23.6x |
19.0x |
| Forward P/E multiples |
18.9x - 24.3x |
21.9x |
| Fair Price |
59.32 - 107.07 |
86.32 |
| Upside |
38.0% - 149.1% |
100.8% |